for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Atyr Pharma Highlighted New External Research Demonstrating Involvement Of Neuropilin Biology In Sars-Cov-2 Infection

June 17 (Reuters) - aTyr Pharma Inc:

* ATYR PHARMA INC - HIGHLIGHTED NEW EXTERNAL RESEARCH DEMONSTRATING INVOLVEMENT OF NEUROPILIN BIOLOGY IN SARS-COV-2 INFECTION

* ATYR PHARMA INC - DISCOVERY THAT NEUROPILIN B1 DOMAIN ACTS AS A BINDING SITE FOR SARS-COV-2 SPIKE PROTEIN AND AIDS VIRAL ENTRY

* ATYR PHARMA INC - ATYR1923, MODULATES NEUROPILIN PATHWAY TO DAMPEN INFLAMMATORY RESPONSES Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up